Erythropoietin stimulates the coronary collateral development in patients with coronary chronic total occlusion

Creative Commons License

Yuksel I. O., Cagirci G., Koklu E., Yilmaz A., Kucukseymen S., Ellidag H. Y., ...Daha Fazla

NETHERLANDS HEART JOURNAL, cilt.24, sa.10, ss.609-616, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 10
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1007/s12471-016-0875-x
  • Dergi Adı: NETHERLANDS HEART JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.609-616
  • Anahtar Kelimeler: Chronic total occlusions, Coronary collateral development, Serum erythropoietin level, SMOOTH-MUSCLE-CELLS, ACUTE KIDNEY INJURY, SERUM ERYTHROPOIETIN, HEART-FAILURE, DNA-SYNTHESIS, INFARCT-SIZE, ACTIVATION, LEVEL, CIRCULATION, ANEMIA
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objective Erythropoietin (EPO) improves cardiac function and induces neovascularisation in post-myocardial infarction heart failure. The aim of this study was to analyse the association between the serum erythropoietin level and coronary collateral development in patients with coronary artery disease and chronic total occlusion.